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ABSTRACT 
Objective: To investigate the radioprotective effect of Ficus racemosa (Fr) ethanol stem bark extract against electron beam radiation (EBR) induced 
DNA damage using in vitro, in vivo and in silico models.  
Methods: The extract of Fr was tested against radiation induced DNA damage by exposing pBR322 plasmid to different EBR dose rates. Comet assay 
was conducted using mice which were exposed at 6Gy EBR. In silico study was performed by inhibiting p53 protein C-chain (1TUP C) using phyto 
chemicals of Fr.  
Results: The in vitro results revealed that, Fr at lower concentration (50µg) showed inhibitory effect on radiation induced DNA damage compared 
with control. Exposure of mice to 6Gy EBR increased comet parameters like TL (Tail length), OTM (Olive tail moment) and %T (percentage of DNA 
in the tail) of blood lymphocytes. Fr ethanol extract given orally prior to irradiation at a dose of 400 mg/kg body weight protected the DNA from the 
radiation damage. The phytochemicals of Fr showed clear interaction with p53 protein chain C, specifically binding to Arginine 248 (ARG248) and 
Arginine 273 (ARG273) amino acid residues thereby inhibiting the p53 protein-DNA interaction upon radiation.  
Conclusion: The present study indicates that Fr ethanol extract significantly reduced radiation induced DNA damage in vivo and in vitro. It also 
showed that the biologically active compounds of Fr have ability to inhibit wild p53 protein which is responsible for apoptosis; these compounds 
can be used as radioprotectors during chemotherapy to protect normal tissues surrounding cancerous tissue.  
Keywords: Ficus racemosa, Radioprotective activity, Molecular docking, p53 protein. 
 
INTRODUCTION 
Radiation therapy is usually applied to the different tumors because 
it uses high energy radiation to shrink tumors and kill cancer cells. 
Ionizing radiation can induce oxidative stress at the cellular level 
which results in the damage of biologically important 
macromolecules such as DNA, proteins, lipids and carbohydrates in 
various organs [1]. DNA lesions can be induced either by direct 
ionization of DNA or indirectly through the reaction of aqueous free 
radicals [2]. Highly reactive oxygen radicals produced by ionizing 
radiation mainly damage DNA which leads to cell killing and 
mutations. Damage to DNA caused by radiation in turn leads to 
activation of p53 protein. This protein acts as a DNA sequence-
specific transcription factor regulating and activating the expression 
of a range of target genes in response to genotoxic stress [3]. This in 
turn initiates a cascade of signal transduction pathways leading to 
altered cellular responses including cell-cycle arrest and apoptosis 
that are well known to prevent cancer development. Amino acids 
i.e. 
Irradiation of normal tissues (wild p53) which are surrounding 
cancerous tissue (mutated p53) during the course of therapeutic 
radiation can result in side effects including mild chronic symptoms, 
acute toxicities, or severe organ dysfunction [5]. Therefore it is 
important to protect DNA from radiation induced damage. There 
have been lots of attempts to find an agent for use in radiation 
therapy that can preferentially protect the normal tissues from 
radiation damage [6]. 
Arg248 and Arg273 are the core residues of p53 protein that 
interact with DNA and suppressions of these two residues are 
proposed to be responsible for inhibition of the p53 protein binding 
to the DNA upon radiation to avoid apoptosis [4].  
Ficus racemosa Linn. (Family: Moraceae) an indigenous medicinal 
plant is used in traditional system of medicine for the treatment of 
several disorders and it is one of the herbs mentioned in all ancient 
scriptures of ayurveda, siddha, unani and homeopathy. Diverse plant 
parts such as bark, root, leaf, fruits and latex are used as astringent, 
carminative, vermifuge and anti-dysentery. The phytochemicals like 
sterols, triterpenoids, alkaloids, tannins, flavonoid and phenols 
isolated from different source of plant was studied [8, 9]. In 
continuation of this line of investigation, the in vivo and in vitro 
protective activity was studied by using EBR as an oxidative DNA 
damaging agent. The in silico radioprotective activity of the 
constituents of Fr was investigated by high throughput screening 
and molecular docking approach. 
However, the fact remains that there is not a 
single radio protective drug available which meets all the 
prerequisites of an ideal radioprotector, which has no toxicity, 
remains stable for a number of years without losing shelf life and 
can be easily administered [7]. In view of this, the search for less 
toxic and more potent radio protective drugs continues. 
MATERIALS AND METHODS 
Chemicals 
TRIS base, high melting agarose, low melting agarose, disodium 
EDTA, tritonX-100, sodium sarcosinate, DMSO and propidium iodide 
for performing comet assay were obtained from Sigma Aldrich (St. 
Louis, Missouri).  
All biological assay reagents, SGPT, SGOT, total bilirubin, ALP, 
albumin, total protein kits and pBR322 plasmid DNA were 
purchased from Bangalore Genei, India. 
Plant material and extraction 
Stem bark of Fr was collected from ethno medical practioner near 
Mala region of Udupi district and was identified and authenticated 
by the expert taxonomist from the Department of Botany, Mangalore 
University, India. The material was shade dried and powdered. The 
powdered sample was extracted by refluxing with the ethanol in 
soxhlet apparatus for 48 hrs. The final extract was filtered, 
concentrated, dried and used for further analysis. 
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Irradiation 
The irradiation work was conducted at Microtron centre, Mangalore 
University, Mangalore, Karnataka, India. The pBR322 plasmid DNA 
containing vials for in vitro study and the animals restrained in well-
ventilated perspex boxes were exposed at a distance of 30 cm from 
the beam exit point of the Microtron accelerator at a dose rate of 72 
Gy/min. 
Estimation of DNA damage in vitro 
To study the protective effect of Fr on DNA strand breaks, the 
pBR322 plasmid DNA sample (250ng in 0.01M sodium phosphate 
buffer) was exposed to EBR at a dose rate of 2Gy/min, 4Gy/min, 
6Gy/min, and 8Gy/min for dose fixation in the absence of drug. After 
irradiation, the DNA samples were electrophoresed on 1% agarose 
gel stained with Gold View containing TAE buffer at 100V for 50 min 
and photographed using UV transilluminator. After dose fixation (i.e. 
4Gy/min) another sets of vials containing pBR322 DNA samples was 
randomly divided into 6 vials. Vial I: normal control i.e. untreated 
DNA, vial II: radiated control exposed to electron beam, vial III, IV, V 
and VI: treated with 50, 100, 150 and 200µg of Fr extract 
respectively and all the vials were exposed to EBR at 4Gy except 
control. After exposure the DNA samples were electrophoresed on 
1% agarose gel stained with Gold View containing TAE buffer and 
photographed using UV transilluminator. 
In vivo study 
Animals 
Animal care and handling were carried out according to the 
guidelines set by the World Health Organization; Geneva, 
Switzerland. The institutional animal ethical committee has 
approved this study. Swiss albino mice aged 6-8 weeks (30±5g) 
taken from an inbred colony, were used for this study. The animals 
were maintained under controlled conditions of 12h light 12 h dark. 
Animals were housed in a polypropylene cage containing sterile 
paddy husk as bedding throughout the experiment. They were 
provided a standard mouse feed and water ad lithium. 
Subchronic toxicity studies 
Subchronic toxicity study of Fr was conducted as described by Miller 
and Tainter [10]. Swiss Albino mice were divided into two groups of 
six animals each and were starved for 18 hr prior to the experiment. 
Group I: control received only distilled water; group II: were fed 
orally with Fr extracts suspended in distilled water at the 
concentration of 2000 mg/kg body weight [11]. Food and water 
intake was monitored daily. After 30 days of treatment animals were 
sacrificed; blood was collected by cardiac puncture. Whole blood 
was centrifuged at 3,500 rpm for 5 min using a table centrifuge 
(Remi. India). The serum was collected and used for the enzyme 
estimation. SGOT and SGPT were estimated according to the 
methods of Reitman and Frankel [12]. ALP was analyzed by the 
method of King and Armstrong [13] while the total bilirubin level 
was estimated as described by Malloy and Evelyn [14].  
Estimation of DNA damage by comet assay 
To carry out in vivo DNA damage studies, animals were randomly 
divided into 5 groups of 6 animals each. Group I served as control 
fed with normal diet and double distilled water, group II animals 
were exposed to EBR, group III animals were administered orally 
with Fr stem bark extract at a dose of 100 mg/kg body weight, group 
IV with 200 mg/kg body weight and group V with 400 mg/kg body 
weight respectively once daily for 15 consecutive days. On the 16th 
day, mice were exposed to 6Gy EBR [15]. After irradiation they were 
observed for the next 15 days. Finally on the 16th
In order to estimate DNA damage in blood lymphocytes, 10μl sample 
was mixed with 200μl of low melting agarose at 37 °C and layered 
on frosted slides pre-coated with 200μl high melting agarose. After 
solidification, the cover slips were removed and the slides were kept 
in pre-chilled lysing buffer for 1 hr. The slides were removed from 
the lysis solution and placed on a horizontal electrophoresis tank 
filled with the alkaline buffer and then equilibrated with the same 
buffer for 20 min. Electrophoresis was carried out for 20 min at 25 V 
and 300 mA and neutralized with 0.4 M Tris, pH 7.4, stained with 
50μl of ethidium bromide and observed using fluorescence 
microscope (Olympus. 40x objective). The level of DNA damage was 
assessed from the DNA migration distance by subtracting the 
diameter of the nucleus from the total length of the comet. 50 
randomly selected cells were examined for each replicate and for 
each sample. The quantification of the DNA strand breaks of the 
stored images was performed using CASP software (www. casplab. 
com) by which the percentage of DNA in the tail, tail length and OTM 
could be obtained directly. 
In silico studies 
QSAR Analysis 
 day the animals 
were sacrificed by cervical dislocation, blood was collected and 
lymphocytes were separated using histopaque and comet assay was 
conducted under alkali conditions according to Singh et al. [16].  
Data sets of 25 compounds of Fr for QSAR analysis were selected 
from the literature (Pubchem database). Chemical structures and 
biological activity for the complete set of compounds were divided 
into training and test sets. The half maximal (50%) inhibitory 
concentration of compounds 
 
(IC50) employed in this study (varying 
from 0.021 to 100 μM), were converted to the corresponding pIC50 (-
logIC50) and used as dependent variables in the QSAR investigations. 
All the details of compounds were represented in (tables 1). From 
the original data set of 25 compounds, 19 compounds were selected 
as members of the training set for QSAR model development, and 
the remaining 7 compounds were considered as members of the test 
set for external validation. Discovery Studio2.5 software (DS 2.5) 
was used to carry out QSAR studies [17]. 
Table 1: Structures, molecular properties and IC50 values of Fr constituents 
S. 
No. 
Name Accession ID IC50 
(μM) 









CID 289984 4.6 1.7 
 
498.7 1 4 7.7 63.6 
 




498.7 1 4 7.4 63.6 
3 α-Amyrin acetate CID 92156 50.0 2.0 
 
468.7 0 2 9.6  26.3 
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4 Bergaptan CID 2355 1.7 2.1 
 
216.1 0 4 2.3 48.7 
5 Βetasitosterol CID 222284 1.9 2.1 
 
414.7 1 1 8.6 20.2 
 




454.6 1 3 7.9 54.3 
 
7 Campesterol CID 173183 2.2 1.92 
 
400.6 1 1 2.2 43.7 
8 Depomedrol CID 5877 26.6 2.07 
 
416.5 2 6 2.7 100.9 
9 Friedeline CID 91472 50.0 1.9 
 
426.7 0 1 7.85 17.0 








CID 68247 12.0 2.0 
 
322.6 5 6 4.3 102 




290.2 5 6 0.7 110 
13 Lupeol CID 259846 10.4 2.0 
 
426.7 1 1 9.9 20.2 






0 2 10.4 26.3 




1 4 1.9 55.8 
16 Mesoinositol CID 892 0.4 2.0 
 
180.1 6 6 -3.7 121 




454.6 1 3 7.2 54.4 
Vinutha et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 6, 110-119 
113 




271.2 4 4 3.2 81.9 




490.4 5 6 0.4 110 
20 Protocatechuin CID 72 0.479 2.1 
 
154.1 3 4 1.1 77.7 
21 Psoralen CID 6199 3 1.9 
 
186.1 0 3 2.3 39.4 




5 1 -2.68 67.2 




414.7 1 1 9.3 20.2 




412.6 1 1 8.6 20.2 
25 Taraxasterol CID 
115250 
0.19 2.1  
 
426.7 1 1 9.1 20.2 
26 Tiglic acid CID 125468 1.3 1.9 
 
100.1 1 2 1 37.3 
Footnote: Mol WT: Molecular Weight; H. B. donor: Hydrogen Bond donor; H. B. Acceptor: Hydrogen Bond Acceptor; Log P: Partition coefficient; 
TPSA: Topological Polar Surface Area 
 
ADMET (Absorption, Distribution, Metabolism, Excretion and 
Toxicity) 
The ADME properties of Fr were calculated using Accelrys Discovery 
Studio software tool in which various pharmacokinetics parameters 
like blood brain barrier penetration (BBB), absorption level solubility 
level, hepatotoxicity, CYP2D6, plasma protein binding (PPB) levels 
were estimated for the compounds listed in (table 1). Obtained results 
were cross checked with standard values [18]. The toxicity profile of 
compounds was predicted using TOPKAT which uses a range of 
quantitative structure toxicity relationship (QSTR) models for 
assessing special toxicological endpoints such as aerobic 
biodegradability, mutagenicity, developmental toxicity prediction and 
skin irritation test [19]. 
Molecular docking 
Molecular docking studies were performed using the phyto 
constituents present in Fr which have a promising role as 
radioprotectors [20]. As stated in the literature, 26 pharmacologically 
relevant compounds of Fr were retrieved from NCBI-Pubchem 
database and were chosen for docking studies. The structures of the 
26 ligands were sketched using Chem. sketch tool (http://www. 
acdlabs. com). The X-ray crystallographic structure of p53protein was 
retrieved from protein data bank (http://www. rcsb. 
org/pdb/files/1TUP. pdb) with PDB ID: 1TUP C-chain. All the 
phytoconstituents were converted into appropriate formats, suitable 
for docking exercises and molecular docking was performed using 
FlexX tool [21].  
Statistical analysis 
RESULTS  
All results were expressed as mean±Standard Deviation (S. D). 
Statistical significance was determined using one-way analysis of 
variance (ANOVA). P values<0.05 were considered as significant. All 
statistical analysis was carried out using Dunnett’s test using instant 
statistical package (Graph Pad Prism version 3.0 software). 
Estimation of DNA damage in vitro 
EBR induced DNA damage occurred 4Gy onwards and at 6 Gy it was 
found irreversible damage and hence 6Gy was considered as toxic 
dose. During exposure to ionizing radiation, the plasmid DNA 
suffered strand breaks, which converted the super coiled (sc) form 
of plasmid DNA to open circular form (oc) (fig. 1). 
The presence of Fr extract during irradiation protected pBR322 DNA 
from radiation damage. 50µg concentrations of the Fr extracts 
showed good protective effect (fig. 2. Lane 3) when compared to 
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irradiate control, indicating that prior treatment of the extracts may 
able to protect the DNA damage during irradiation. 
 
 
Fig. 1: Damage of pBR322 DNA by EBR; C: Control, R: Radiated, 
OS: Open Circular, SC: Super Coiled 
 
 
Fig. 2: In vitro radioprotective activity of Fr at different 
concentrations; C: Control, R: Radiated, OS: Open Circular, SC: 
Super Coiled 
Subchronic toxicity studies 
The effect of Fr extract on serum biochemical parameters are 
presented in (table 2). The levels of serum enzymes such as SGOT, 
SGPT, ALP; albumin, total protein and bilirubin content were not 
significantly different compared to control groups. 
Estimation of DNA damage by comet assay  
Exposure of control mice to EBR increased comet parameters 
like TL, OTM and %T of blood lymphocytes, suggesting radiation-
induced damage to DNA.  
Table 3 showed that when the Fr treated mice were exposed to 
EBR, the comet parameters in lymphocytes cells were increased 
compared to control groups i.e. from 7.3±1.61, 0.6037±0.066 and 
0.5126±0.181 to 234.2±1.4, 39.62±1.64 and 16.623±1.639 
respectively.  
An administration of Fr extracts orally prior to irradiation at a dose 
of 400 mg/kg body weight protected the DNA from damage when 
compared to other lower concentrations i.e. 100 and 200 mg/kg 
body weight respectively which indicates the concentration 
dependent DNA protection. 
 
Table 2: Effect of Fr extract on the function of liver enzymes 
Tests SGOT (U/l) SGPT (U/l) ALP (U/l) Total protein (g/dl) Albumin (g/dl) Total bilirubin (mg/dl) 
Control 19.525±0.4 27.55±0.4 77.69±0.09 7.26±0.46 2.153±0.37 2.1815±0.27 
Fr 19.54±0.36 26.92±0.45 77.525±0.95 7.32±0.31 2.320±0.34 2.57±0.41 
Footnote: Values are expressed as mean±SD 
 
Table 3: In vivo radioprotective activity of Fr extract using comet assay 
Groups Tail Length %T OTM 
Control 7.3±1.61                                                 0.6037±0.066 0.5126±0.181 
Irradiated control 234.2±1.4 39.62±1.64 16.623±1.639 
Fr 100 mg/kg 137±0.9 19.17±1.137 9.545±1.983 
Fr 200 mg/kg 103.4±1.685 6.641±0.7315** 4.1928±0.494** 
Fr 400 mg/kg 81.5±0.921*** 6.516±0.7227*** 3.015±0.770*** 
Footnote: Values are reported as mean±S. E. M. for a group of six animals. Asterisks indicated statistically significant values when compared to 
radiation. *p<0.05, **p<0.01, ***p<0.001 
 
Table 4: Predicted and actually values of 19 training set and 7 test set compounds 
S. No. Fr constituents pIC50 (Actual) GFATemp Mdel_1(Predicted) 
Training set 
1 Acetylbetulinic acid 1.73 1.72 
2 Acetylursolic acid 1.81 1.81 
3 α-Amyrin acetate 2.01 2.48 
4 Bergaptan 2.13 2.17 
5 Betasitosterol 2.15 2.17 
6 Campesterol 1.92 1.94 
7 Leucantcyanidin 2.04 2.10 
8 Leucopelargonidn 1.78 1.80 
9 Lupeol 2.09 2.10 
10 Lupeol acetate 2.10 2.13 
11 Mesoinositol 2.00 2.03 
12 Perlargonidin 1.92 1.95 
13 Protocatechin  2.11 2.13 
14 Psoralen 1.91 1.93 
15 Racemosic acid 1.73 1.73 
16 Rutin 1.92 1.95 
17 Stigmasterin 2 1.95 
18 Taraxasterol 2.11 2.15 
19 Tiglic acid 1.91 1.92 
Test set 
1 Kampferol 1.87 1.86 
2 Oleanonic acid 2.32 2.31 
3 Marmesin 1.98 1.97 
4 Transcatechin 1.95 1.95 
5 Friedeline 2.40 2.38 
6 Betulonic acid 2.00 2.01 
7 Depomedrol 2.86 2. 84 
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In silico studies 
QSAR analysis 
The results of external validation for Fr were listed in (table 4) 
and the graphical representation for the experimental activity 
versus GFA Temp Mode_1 (predicted activity) of both training 
set and test set were displayed in (fig. 3, fig. 4). All the 
descriptors were taken as independent variables on X-axis and 
biological active values of compounds were taken as dependent 
variable on Y-axis, and GFA model was performed for all the 
phytoconstituents and statistical analysis of the training set 
compounds were represented in (table 5). 
 
 
Fig. 3: Activity values predicted by GFA model of training set 
compounds of Fr 
 
Fig. 4: Activity values predicted by GFA model of test set 
compounds of Fr
 
Table 5: Statistical analysis of training set compounds of Fr 
 r (adj)r2 (pred)r2 RMS residual error 2 Fried man LOF S. O. R. p-Value 
Equation 1 0.995 0.998 0.992 0.018 0.095 1.33E-05 
Footnote: r2 is coefficient of determination; r2 (adj) is r2 adjusted for the number of terms in the model; r2 (predicted) is the prediction (PRESS) r2, 
equivalent to q2
 
The first best equation bearing the relevant descriptors are given as 
GFA Template model1 below 
GFATempMode1= 2.0233+0.54829; ALogP–0.93868; Molecular 
fractional polar surface area–0.80254; Molecular weight–0.54158; 
Number of hydrogen donor-1.5164; Number of hydrogen 
acceptor+2.8333; number of rotatable bonds–1.1912; number of 
rings–0.98855; Number of aromatic rings+0.00257542 
From the GFATempMode1, we can deduce that the 2D descriptors 
showing good correlation (as+sign indicate positive correlation) of 
the molecules structure properties with its biological activity. 
Although the classical 2D QSAR model provided some useful 
information and showed a good predictive ability, on which moieties 
are particularly important to p53 protein inhibition. 
ADMET  
Various pharmacokinetics and pharmacodynamics properties like 
aqueous solubility, human intestinal absorption, PPB, BBB 
penetration, cytochromep450 inhibition and hepatotoxicity levels 
were predicted for Fr compounds and represented in (table 6).  
 from a leave-1-out cross-validation; Friedman L. O. F. is the Friedman lack-of-fit score; S. O. R. p-value is the p-value for significance 
of regression. 
The interpretation of the values was done using standards provided 
by Accelrys Inc. The graphical representation of ADMET properties 
are shown in (fig. 5). TOPKAT studies predicted aerobic 
biodegradability, mutagenicity, developmental toxicity potential 
(DTP), skin irritant and carcinogenicity of the compounds of Fr were 
represent in (table 7). 
Molecular docking studies 
The docking of phytoconstituents from plant Fr to 1TUP C protein 
reveal that the stretch of amino acid residues from Lys 132 to Glu 
285 in the p53 protein broadly interact with the ligands and 
interestingly coincide with the p53-DNA binding interacting 
residues i.e. Arg248 and Arg273. The docking scores were obtained 
from the compounds with 1TUP C as the receptor. The output of all 
the ligands is indicated by energy values in kcal/mol. Least the 
energy values strongest is the interaction. Among 26 ligands, 7 
ligands inhibited p53 protein like Kampferol, Oleanonic acid, 
Marmesin, Transcatechin, Friedeline, Betulonic acid and 
Depomedrol were represented in the (table 8). 
 
 
Fig. 5: ADMET properties of Fr ethanol extract 
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Table 6: Predicted ADME profiles of Fr compounds 
S. No. Name BBB level Absorption level Solubility level Hepatotoxicity CYP2D6 PPB level 
1 Acetylbetulinic acid 4 1 0 0 0 2 
2 Acetlyursolic acid 4 1 0 1 1 2 
3 α-Amyrin acetate 4 1 0 0 0 2 
4 Bergapten 2 0 3 0 0 1 
5 Βetasitosterol 4 1 0 0 0 2 
6 Betulonic acid 4 0 1 0 0 2 
7 Campesterol 4 0 3 1 1 1 
8 Depomedrol 4 0 3 0 0 2 
9 Friedeline 4 0 3 0 0 2 
10 Kampferol 4 0 3 0 0 2 
11 Leucoantho cyanidin 4 1 5 1 0 0 
12 Leucopelargonin 3 0 3 1 1 2 
13 Lupeol 3 0 4 0 0 1 
14 Lupeal acetate 2 0 3 0 0 2 
15 Marmesin 4 0 3 0 0 0 
16 Mesoinositol 4 3 3 1 0 2 
17 Oleanonic acid 3 0 3 0 0 0 
18 Perlargonidin 4 3 1 1 0 2 
19 Transcatechin 2 0 3 0 0 1 
20 Protocatechuin 4 3 0 0 0 2 
21 Psoralen 2 0 4 0 0 0 
22 Racemosic acid 4 2 0 0 0 2 
23 Rutin 4 2 0 0 0 2 
24 Stigmasterin 4 3 0 0 0 2 
25 Taraxasterol 3 0 3 0 0 2 
26 Tiglic acid 4 0 3 0 0 0 
 
Table 7: Predicted TOPKAT profile of Fr compounds 
S. 
No. 





Rodent Female mouse Male mouse 
1 Acetylbetulinic acid No Non-Mutagen No No No No No 
2 Acetlyursolic acid No Non-Mutagen No No No No No 
3 α-Amyrin acetate No Non-Mutagen No No No No No 
4 Bergaptan No Non-Mutagen No No No No No 
5 Βetasitosterol No Non-Mutagen No No No No No 
6 Betulonic acid No Non-Mutagen No No No No No 
7 Campesterol No Non-Mutagen No No No No No 
8 Depomedrol No Non-Mutagen No No No No No 
9 Friedeline No Non-Mutagen No No No No No 
10 Kampferol No Non-Mutagen No No No No No 
11 Leucoantho cyanidin Yes Non-Mutagen No No No No No 
12 Leucopelargonin No Non-Mutagen No No No No No 
13 Lupeol Yes Non-Mutagen No No No Yes Yes 
14 Lupeal acetate Yes Non-Mutagen No No No No No 
15 Marmesin No Non-Mutagen No No No No No 
16 Mesoinositol No Non-Mutagen No No No No No 
17 Oleanonic acid No Non-Mutagen No No No No No 
18 Perlargonidin No Non-Mutagen No No No No No 
19 Transcatechin Yes Non-Mutagen No No No No No 
20 Protocatechuin Yes Non-Mutagen No No No No No 
21 Psoralen Yes Mutagen No No No No No 
22 Racemosic acid Yes Mutagen No No No No No 
23 Rutin Yes Non-Mutagen No No No Yes Yes 
24 Stigmasterin No Non-Mutagen No No No No No 
25 Taraxasterol No Non-Mutagen No No No No No 
26 Tiglic acid No Non-Mutagen No No No No No 
 
Table 8: Docking of constituents of Fr to 1TUP C protein 
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Radiotherapy one of the treatments for cancer, faces a major drawback 
as it inevitably involves exposure of normal tissues to the deleterious 
effects of ionizing radiation. Damage to DNA and membrane lipids is the 
critical factors in radiation-induced cellular damage and reproductive 
cell death [22]
The alkaline comet assay is an elegant and effective technique to 
monitor the extent of DNA damage and its protection. When mice 
were exposed to EBR, the cellular DNA undergoes damage, as 
reflected by increase of the comet parameters like TL as it shows 
breaks in DNA and its density, similarly OTM as it indicates 
fragmentation of DNA and % T because it provides a quantitative 
measure of the damaged DNA when compared to control [25]. The 
presence of Fr extracts during EBR exposure showed reduction in 
comet parameters when compared to irradiated (table 3), indicating 
its significant role in radioprotection. 
. Herbal medicines have been gaining importance in 
radioprotective drug discovery owing to lesser side effects as reviewed 
extensively by many authors [23].  Protective effect of Fr extract and its 
constituents on radiation induced DNA damage was studied using in 
vitro, in vivo and in silico models. When pBR322 plasmid DNA exposed to 
4 Gy EBR, super coiled form of DNA converted in to open circular form 
because of the induction of strand breaks in the DNA. Treatment with Fr 
extract with different concentrations before 1 hr of radiation exposure 
gives a dose dependent protection which can be explained by checking 
the depletion of oc form of DNA to sc form (fig 2). This result is similar to 
work reported by Nitin et al. [24], who showed that 
diethyldithicarbamate along with γ irradiation resulted in a significant 
protection of pBR322 DNA damage in a dose-dependent manner 
compared with control mice. 
QSAR a broadly used tool for developing relationships between the 
activities and properties of a series of molecules with their 
structural properties. The QSAR of constituents of Fr was assayed 
using Discovery Studio 2.5. The analyses showed statistical values 
for the best models as represented in (table 5). The model when 
validated using LOF method showed a cross-validated correlation 
coefficient (q 2) value of 0.992, and a good predictive value (adj r 2, 
external validation) of 0.998. In this QSAR model, 99.5% of the 
variance in biological activity was predicted, as indicated by 
r 2 values of 0.995 multiplied by 100. The QSAR model equation 
revealed the relationship between experimental activity (i.e. the 
inhibitory concentration to 50% of the population [pIC50]) as the 
dependent variable and chemical descriptors as independent 
variables. Thus, in the present study the QSAR experiment 
successfully developed a GFA mathematical model for drug activity 
prediction. This finding was supported by Sarfaraz et al. [26] where 
similar work was carried out on xanthone derivatives for anticancer 
activity.
Prediction of ADMET properties plays an important role in the drug 
design process. ADMET is applied at an early phase of drug 
development process in order to remove the molecules with poor 
ADMET properties [27]. According to Venkataramana et al. [28], 
aqueous solubility of the compounds helps to predict the percentage 
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of solubility of drugs in water. Based on the results obtained, the 
compounds may have good solubility so that they can have complete 
oral absorption for effective dosage. Reddy et al. deduced that blood 
brain penetration level shows the penetrating efficacy of the 
compound towards the brain and from the results it is observed that 
all compounds were fallen outside the 99% ellipse. Hence the 
compounds may not be able to penetrate the blood brain barrier. So, 
the chances of central nervous system side effects are low or absent. 
BBB scores of compounds have shown variable penetrating efficacy. 
Kampferol, Marmesin, Oleanonic acid, Friedeline scored 0 which 
implies that these compounds do not inhibit CYP2D6 enzymes when 
they undergo metabolism via cytochromep450. According to Durga 
et al. [29], PPB level shows whether the compound binds to carrier 
proteins in the blood [30]. The compounds of Fr showed to have 
good binding capacity to cross the membrane and bind to plasma 
protein. Hepatotoxicity level predicts organ toxicity of the molecule 
and it falls in two levels; zero for non-toxic and one for toxic. Based 
on these tested levels, the results suggest that the compounds were 
non-toxic and can be used for further studies. 
During radiation induced DNA damage or oxidative stress caused by 
radiation, transcription factor p53 is activated and stabilized. 
Consequently, p53 up-regulates the gene expression that facilitates 
apoptosis or leads to genomic instability [31]. Mutations induced by 
radiation in p53 protein leads to conformational changes of the 
protein and also cause loss of its function. Further loss of its 
apoptotic function can lead to development of radio and drug 
resistant cancer cells and in turn to severe side effect to normal 
tissue surrounding cancerous tissue [32].  
Hence the protection of normal tissues from radiation damage is of 
primary importance. Small molecules such as PRIMA-1, RITA, and 
pifitrin-α, changes the sterical conformation of mutated p53 back to 
the conformation of wild-type p53 [33]. A novel concept is targeting 
tumor suppressor p53 as a key player of apoptosis to reach 
radiosensitization of tumors and in turn radioprotection of normal 
tissues. Hence inhibition of the function of wild-type p53 using Fr 
constituents may suppress induction of apoptosis in normal tissues 
by targeting ARG 248 and ARG 273 and hence, may prevent 
radiotherapy associated side effects in cancer patients and protect 
the normal cells damage. 
CONCLUSION 
The results indicate that the presence of Fr ethanol extract during 
EBR protected pBR322 DNA damage and even damage of 
lymphocyte cells of mice. In depth the compounds of Fr mainly 
Kampferol, Marmesin, Oleanonic acid, Friedeline, Depomedrol and 
Betulonic acid obtained from literature significantly interacted and 
inhibited p53 protein thereby inhibiting the process of apoptosis 
The present studies may be helpful in offering promising leads 
towards development of radioprotectors in turn protecting the 
normal tissue from radiation damage.  
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